Alliancebernstein L.P. Vaxart, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.75 - $2.24 $46,200 - $137,984	61,600 Added 47.57%	191,100 $183,000
Q3 2022 Nov 15, 2022	BUY	$2.09 - $4.5 $49,742 - $107,100	23,800 Added 22.52%	129,500 $282,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $79,380 - $155,232	29,400 Added 38.53%	105,700 $370,000
Q1 2022 May 13, 2022	BUY	$4.29 - $6.64 $858 - $1,328	200 Added 0.26%	76,300 $385,000
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $174,831 - $241,188	-30,300 Reduced 28.48%	76,100 $477,000
Q3 2021 Nov 10, 2021	BUY	$6.67 - $9.8 $100,717 - $147,980	15,100 Added 16.54%	106,400 $846,000
Q2 2021 Jul 30, 2021	BUY	$5.06 - $10.78 $241,867 - $515,283	47,800 Added 109.89%	91,300 $684,000
Q3 2020 Nov 12, 2020	SELL	$4.78 - $16.97 $207,930 - $738,195	-43,500 Reduced 50.0%	43,500 $289,000
Q2 2020 Aug 13, 2020	BUY	$1.68 - $8.85 $146,160 - $769,950	87,000 New	87,000 $770,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.